Patients who developed breast mesh complications over 90 days after a documented breast mesh implantation may qualify to file a lawsuit and pursue financial compensation with the help of our experienced defective medical device lawyers.
Breast mesh litigation alleges that patients have developed serious complications after receiving surgical mesh product implants that have never been cleared or approved for use in breast procedures by the FDA.
Internal Bra Mesh Lawsuit: Key Takeaways
- The FDA has not approved any surgical mesh product for breast reconstruction, augmentation or lift procedures.
- Patients who suffered infection, mesh failure or revision surgery after mesh implantation may qualify to file a lawsuit with the help of the internal bra mesh lawyers at Nadrich Accident Injury Lawyers.
- Defendants in lawsuits include manufacturers such as Becton, Dickinson and Company, C.R. Bard, Allergan and Integra LifeSciences.
- The values of breast mesh lawsuit settlements depend on complication severity, documentation and number of revision surgeries.
- Deadlines to file internal bra lawsuits begin when patients discover their injuries are related to their breast surgery involving mesh, not the date of the surgery.
Call our experienced breast mesh attorneys today for a FREE consultation at (800) 718-4658 or contact us if you or a loved one developed complications after receiving a breast mesh implant. We can help you recover financial compensation for medical bills, lost wages, pain, suffering and more, and we will charge you no legal fee until we win your case.
Why Breast Mesh Injury Victims Trust Our Lawyers
- Many defective medical device lawyers accept all the cases they can regardless of whether they have the staff to handle them all. Our responsive legal team, however, is fully staffed so we can provide breast mesh clients with reliable communication, 24/7 availability and frequent case updates.
- We have been trusted since 1990 to help victims of defective medical devices seek fair compensation for their injuries.
- We provide free consultations and we will charge you no legal fee until we win your internal bra mesh claim.
- Our high-stakes litigation team has the experience in handling large defective medical device claims and the comprehensive resources to take on big medical device companies like C.R. Bard and Allergan in court.
- While many lawyers who handle cases involving internal bra complications are willing to settle cheaply for a quick buck, our trial-ready representation is ready and willing to fight for you in court.
- We and our legal teams have recovered over $750 million on behalf of defective medical device clients and other injury clients.
Past results do not guarantee future outcomes. All cases are unique and results depend on cases’ specific facts.
Table of Contents
- What Is an Internal Bra Mesh Implant?
- Who Can File an Internal Bra Mesh Lawsuit?
- Which Breast Mesh Products Are Involved in Lawsuits?
- What Did the FDA Say About Breast Mesh Safety?
- What Complications Have Been Linked to Breast Mesh?
- What Is the Average Settlement for a Breast Mesh Lawsuit?
- How Long Do I Have to File a Breast Mesh Lawsuit in California?
- Frequently Asked Questions
- Request a Free Internal Bra Mesh Case Review
- Breast Mesh Lawsuit Updates
What Is an Internal Bra Mesh Implant?
The internal bra technique uses mesh to reinforce breast tissue and support implants.
Surgeons use the internal bra procedure during implant-based breast reconstruction surgery, breast augmentation, and revision or breast lift surgery.
Two primary types of breast mesh are biologic and synthetic. Biologic mesh includes acellular dermal matrix such as AlloDerm or Strattice and synthetic mesh includes GalaFLEX and Phasix.
Synthetic mesh includes materials such as poly-4-hydroxybutyrate (P4HB), a bioresorbable polymer.
Biologic mesh is derived from processed animal tissue or processed human tissue.
Many patients only learn of the use of mesh in breast surgery after complications develop.
Who Can File an Internal Bra Mesh Lawsuit?
Patients with documented breast mesh implantation who developed a qualifying complication over 90 days post-surgery may qualify to file a lawsuit.
Qualifying surgery types include:
- Post-mastectomy reconstruction
- Cosmetic augmentation
- Breast lift
- Revision surgery
Qualifying complications include:
- Capsular contracture
- Deep tissue infection or abscess
- Tissue necrosis
- Implant rupture
- Subsequent explant or revision surgery
Standard surgical scarring and minor revisions unrelated to mesh typically do not support claims on their own.
Eligibility does not depend upon knowing the exact product name at the time of inquiry.
Our attorneys can help you request surgical records to confirm which mesh was used.
Which Breast Mesh Products Are Involved in Lawsuits?
Becton, Dickinson and Company, as well as C.R. Bard, are facing lawsuits linked with GalaFLEX and Phasix mesh products.
AbbVie and its LifeCell subsidiary are facing lawsuits involving AlloDerm and Strattice biologic tissue matrices.
Integra LifeSciences is facing lawsuits linked with DuraSorb and SurgiMend mesh products.
The FDA has not cleared or approved any surgical mesh product to be used as surgical mesh in breast surgery. The products discussed above may be legally marketed for general soft-tissue reinforcement or reconstruction purposes. However, their use as an internal bra in breast procedures has not been cleared or approved by the FDA.
What Did the FDA Say About Breast Mesh Safety?
No surgical mesh has been approved by the FDA for breast surgery.
The FDA has stated that the safety of surgical mesh regarding breast surgery is undetermined.
The agency has issued a warning in 2023 regarding the increase of mesh use in breast surgery.
The FDA, in 2023, sent healthcare providers a letter advising them to read the updated labeling for Becton, Dickinson and Company mesh products.
The agency has warned about higher complications rates regarding certain acellular dermal matrix products.
The FDA updated labels for Phasix and GalaFLEX mesh products in 2023.
The agency has not recommended the removal of mesh from patients without symptoms.
What Complications Have Been Linked to Breast Mesh?
Infections and chronic pain are injuries which have been commonly linked to breast mesh.
Additional complications may include implant loss, capsular contracture, seroma, mesh migration, fluid buildup, tissue necrosis, reconstruction failure, implant displacement, mesh hardening or erosion, and need for revision or explant surgery.
A 2021 study found that numerous complications happened within six months of surgery involving breast mesh devices. 34 percent of patients experienced complications, and around 13 percent of patients required the surgical removal of their implants. Issues associated with the mesh happened as long as three years after the first surgery.
Reoperation rates have reached almost 10 percent in breast reconstruction studies.
A former medical director at a manufacturer involved in breast mesh lawsuits has raised concerns that the use of mesh could complicate the detection of recurrent breast cancer.
Documentation of every complication and treatment strengthens breast mesh claims.
Lawsuits allege that breast mesh manufacturers failed to warn about risks of mesh failure and infection.
What Is the Average Settlement for a Breast Mesh Lawsuit?
Settlements have typically spanned from tens of thousands of dollars for claims which involved limited infections to several hundred thousand dollars for cases which involved multiple revision surgeries or permanent disfigurement. Settlement amounts depend upon injury severity, documentation and case specifics.
Compensation may cover medical bills, lost wages, pain, suffering and more.
Past hernia mesh settlements and transvaginal mesh lawsuits can provide context regarding breast mesh claims, although hernia mesh outcomes cannot predict breast mesh results. 2024 saw C.R. Bard reach a settlement which has been estimated at over $1 billion to resolve about 40,000 hernia mesh claims. That works out to at least $25,000 per case. Bard is now facing scrutiny over its breast mesh products such as AlloMax and Phasix.
Every case is different and no outcome is guaranteed.
Our law firm can help you seek fair compensation for:
Medical Bills
We can help you seek compensation for past and future medical expenses related to your mesh implant complications, including compensation for the costs of things such as ER visits, hospital stays, surgeries, medications, medical procedures, medical testing, doctor visits, physical therapy, rehabilitation and more.
Lost Wages
Our firm can help you seek compensation for any wages you’re unable to earn due to being too unwell to work or due to having to miss work to attend medical appointments.
Loss of Earning Capacity
We can help you seek compensation for any loss or reduction of your earning capacity caused by a disability resulting from breast mesh complications.
Pain and Suffering
Our firm can help you seek compensation for the physical pain, mental suffering, emotional distress and lost quality of life linked with your breast mesh complications.
Wrongful Death
If you lost a loved one to breast mesh complications, we can help you seek compensation for:
- Funeral and burial costs
- The medical bills incurred by your loved one before they passed
- The pain and suffering your loved one endured before they passed
- The loss of your loved one’s love, companionship, income, spousal benefits and household services
How Long Do I Have to File a Breast Mesh Lawsuit in California?
Most breast mesh victims will have two years from the date they discovered that their injuries were caused by a breast mesh product to file a lawsuit seeking financial compensation for their injuries under California Code of Civil Procedure Section 335.1.
There are exceptions to this two year time limit, though. Some can extend it and some can shorten it. Deadlines can vary for claims against government-affiliated medical providers.
Seek consultation with a lawyer promptly to make sure evidence is preserved and your legal rights are protected.
Frequently Asked Questions
How Do I Know If I Had an Internal Bra Mesh Used in My Surgery?
Surgical and operative records usually identify the exact product that was used.
Our attorneys can help request these records on your behalf.
Contact the original surgical facility directly if records are not on hand.
Can I File a Claim if My Surgery Was Cosmetic Rather Than Reconstructive?
Yes. Patients injured after elective augmentation, lift or revision surgeries may qualify to file lawsuits.
Eligibility depends on the complication and your documentation, not your original reason for surgery.
What Does It Cost to Hire a Breast Mesh Lawyer?
Our breast mesh lawyers operate on a contingency fee basis. This means that our only attorney fees are a percentage of any compensation we recover on your behalf. These fees are not charged until the end of the case, and are not charged if no recovery is obtained.
Request a Free Internal Bra Mesh Case Review
Call us today for a FREE consultation at (800) 718-4658 or contact us if you or your loved one developed complications after having received a breast mesh implant.
We can help you recover financial compensation and we will charge you no legal fee until we win your case.
Call us today.
Breast Mesh Lawsuit Updates
July 20, 2026 Update
A new analysis has indicated that the market for breast reconstruction mesh will likely substantially expand in the near future, possibly exposing additional women to products which are currently being subjected to lawsuits involving disfiguring, painful complications.
A market analysis which was recently released by The Business Research Company predicts that growth will continue in this market through 2030.
The report estimates that the market, globally, will reach $840 million by the year 2030, comprising a 6.6 percent compound annual growth rate.
The prediction is notable since medical device manufacturers are facing lawsuits which allege they sold products for use during breast procedures without adequate safety data or FDA approval.
The lawsuits allege patients weren’t adequately warned that the mesh products could migrate, contract, fail to dissolve or lead to complications which require surgery and additional treatment.
May 26, 2026 Update
An increasing number of women are reporting debilitating, painful complications regarding GalaFLEX mesh, often leading to a need for breast implant removal or revision surgery, after this mesh product was used off-label for breast reconstruction, lift or augmentation surgery.
While GalaFLEX mesh has never been approved for use inside the breast, critics have claimed that manufacturers have sold mesh products directly to reconstructive and cosmetic surgeons, knowing the products would be used as “internal bras” during breast procedures.
Women are now alleging they weren’t adequately warned about the risk of problems with the breast mesh, including design defects which may cause the mesh to become painful, fail inside the breast, promote infections, shift out of position or cause a need for removal surgery.
The last several years have seen reports submitted to the FDA MAUDE database regarding GalaFLEX complications involving:
- Failure to incorporate into tissue
- Mesh rolling beneath the skin
- Seroma
- Infection
- Wound breakdown
- Hematoma
- Bottoming out
- Implant displacement
- Breast deformity
- Chronic pain
May 5, 2026 Update
The past week has seen multiple women file lawsuits against the manufacturers of GalaFLEX mesh, alleging they were left with devastating, painful injuries by the mesh.
The lawsuits allege that Becton Dickinson has been aware of the possible risks with using the mesh as an internal bra for many years, yet has continued to sell the products for use in this manner.
2019 saw FDA officials warn that no scaffold mesh has been evaluated and approved for the use in breast surgery.
The recently filed lawsuits all describe similar reports of complications, pain and a need for revision surgery.
The lawsuits outline a history of issues involving the use of these products in breast surgery, indicating that this didn’t stop Becton Dickinson from selling GalaFLEX mesh for off-label use.
The lawsuits claim that Becton Dickinson continued to market, sell, distribute and promote GalaFLEX mesh after learning that the mesh was failing and failing to perform as intended and represented, showing a conscious disregard or complete indifference to the safety of others.
January 27, 2026 Update
A lawsuit claims that a patient experienced complications following the use of surgical mesh during a cosmetic breast procedure.
The plaintiff alleges she needed multiple revision procedures after the complications developed.
The lawsuit alleges that the following occurred:
- Bleeding
- Hematoma
- Extended recovery
- Additional surgeries
- Medical expenses
- Pain and suffering
- Lost income
- Corrective care
December 11, 2025 Update
Surgeons are raising concerns about the increasing use of internal bra mesh products for cosmetic breast procedures. They are warning that these materials could be leading to preventable, painful complications.
Dr. Jeffrey Lind, in a TikTok video, explains why he avoids the use of internal bra mesh during cosmetic surgeries.
He explains that the use of mesh in cosmetic breast surgery has not been based upon clinical evidence.
Dr. Lind says the problem isn’t just complications that he encounters, but patients being sold on a procedure which lacks benefit that has been proven. He says he hasn’t seen definitive evidence where the internal bra technique has provided any benefit. He claims it increases the cost of surgery and increases the risk of future surgery.
He explains that he recently had a patient who had “very bad” complications from an internal bra, involving mesh which failed to incorporate into the tissue, calling the situation a “complete disaster.”
Dr. Lind says that the risks of the procedure outweigh any possible benefit.
Dr. Rami Sherif, in a YouTube video, notes that the long-term results of mesh used in breast surgery are often disappointing.
He explains that while the purpose of mesh is to prevent breast tissue or implants from drooping lower on the chest wall, the internal bra technique doesn’t reliably prevent this, and can create more complications by introducing a foreign device inside the body.
Dr. Sherif noted he sees a lot of patients who need explant or revision surgery after having mesh placed during earlier breast procedures.
Dr. Sherif explains that breast mesh adds an additional complicating factor to surgery without consistently providing benefit.
November 14, 2025 Update
A former company insider and prominent patient safety advocate is warning about GalaFLEX surgical mesh’s off-label use in breast surgery, indicating that the safety and effectiveness of the device haven’t been proven and that the use of the product could expose patients as well as surgeons to serious risks.
Dr. Hooman Noorchashm says that Becton, Dickinson and Company fired him in 2022 after he objected to what he calls unsafe marketing as well as investigational use of GalaFLEX mesh during breast surgery.
Dr. Noorchashm says he has witnessed how the device, originally designed to be used for soft tissue repair, is now getting promoted for the use in breast surgery without proper oversight, study or FDA approval.
Dr. Noorchashm is urging surgeons, insurers and regulators to stop the unapproved use of the product, warning that more and more women are going through breast procedures using a device that is considered investigational by U.S. law.
He claims he was fired after he voiced concerns that a mesh made from P4HB, the same material that is used in GalaFLEX mesh, may provoke biological reactions which increase the risk of breast reconstruction patients having cancer recurrence.
He also alleges that a study involving P4HB led to several unreported recurrences of cancer and didn’t have the necessary federal authorization to use a device which is investigational.
Dr. Noorchashm is arguing that P4HB interacts with the immune system in a way that can activate M2 macrophages, cells that are linked with tumor-promoting environments as well as dense fibrotic tissue. He is warning that the scarring that results can obscure ultrasounds or mammograms, delaying the detection of breast cancer.
He has accused industry consultants of advertising that is misleading and implies FDA approval while downplaying an absence of clinical data.
November 10, 2023 Update
The FDA has issued a letter to healthcare providers informing them about changes to some Becton Dickinson mesh product labels that clarify that the manufacturer hasn’t established that the mesh is effective or safe for breast reconstruction.
The products receiving this updated label warning include:
- Phasix ST Mesh
- Phasix Mesh
- Phasix ST Mesh with Open Positioning System (OPS)
- Phasix Plug and Patch
- GalaFLEX Lite Scaffold
- Phasix ST Mesh with Echo 2 Positioning System
- GalaFLEX 3DR Scaffold
- GalaFLEX 3D Scaffold
- GalaFLEX Scaffold
The products have been cleared for the reinforcement and repair of soft tissue, but not for breast surgery.
